Neuroscience Grand Rounds: "Targeted Therapy for Brain Tumors"
Password: 553771
Meeting ID: 945 0718 2894
CME TEXTING CODE: 40082
Program Goals:
- Understand clinical trial design in Neuro-Oncology
- Recognize emerging role of mutant IDH enzyme in glioma classification and treatment
- Discuss future opportunities for targeted therapies
Speaker
Memorial Sloan Kettering Cancer Center
Ingo Mellinghoff, MDChair, Department of Neurology; Evnin Family Chair in Neuro-Oncology; Human Oncology and Pathogenesis Program
Contact
Admission
Free
Tag
Grand Rounds